TFIIB-related factor 2 over expression is a prognosis marker for early-stage non-small cell lung cancer correlated with tumor angiogenesis.

PLoS One · 2014 · PMC3921153 · PMID 24523874

Europe PMC DOI

hedged sentence

0.0030

closest p · 0.1× alpha

0.0030

boldest claim

The sentences

highly significantP = 0.003actually significant

For patients without BRF2 overexpression, we detected a highly significant inferior overall survival (OS) and Disease-free survival (PFS), respectively, in patients with high MVD compared with patients with low MVD (P = 0.003 for OS and P = 0.001 for PFS, Table 5 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.